Scholars Central

EditorialPublished 31 Jul 2023

Immunogenicity of Biopharmaceuticals: The Immune Response to Therapeutic Proteins

Authors: Zheng Tay

Department of Biological Sciences, National University of Califonian, Japan

Journal of Cytokine Biology

Volume 8 · Issue 4 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A serious clinical event is when an immune response to a therapeutic protein interferes with the biopharmaceutical activity or interacts with an endogenous protein. In recent years, a lot of attention has been paid to the role that protein aggregates and particles in biopharmaceutical formulations play in mediating this immune response. Model frameworks that could reliably and dependably foresee the general immunogenicity of biopharmaceutical protein definitions would be incredibly significant. In an effort to provide this insight, a number of methods, such as in silico algorithms, in vitro tests using human leukocytes, and in vivo animal models, have been developed.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Cytokine Biology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cytokine Biology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Zheng Tay”